NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
7.87
-0.48 (-5.75%)
May 15, 2026, 4:00 PM EDT - Market closed
NeurAxis Market Cap
NeurAxis has a market cap or net worth of $90.55 million as of May 15, 2026. Its market cap has increased by 443.22% in one year.
Market Cap
90.55M
Enterprise Value
83.82M
1-Year Change
443.22%
Ranking
Category
Stock Price
$7.87
Market Cap Chart
Since the IPO on August 9, 2023, NeurAxis's market cap has increased from $18.37M to $90.55M, an increase of 392.86%. That is a compound annual growth rate of 77.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 90.55M | 87.22% |
| Dec 31, 2025 | 48.36M | 194.84% |
| Dec 31, 2024 | 16.40M | 16.15% |
| Dec 29, 2023 | 14.12M | -23.13% |
| Aug 9, 2023 | 18.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vivani Medical | 103.48M |
| Biomea Fusion | 103.39M |
| LeonaBio | 103.33M |
| Oncolytics Biotech | 101.37M |
| Aldeyra Therapeutics | 100.13M |
| Seer, Inc. | 98.74M |
| Anixa Biosciences | 96.90M |
| ProMIS Neurosciences | 94.88M |